Physician profile
Solomon Azouz
NPI 1366838864
$15,630.49
in general payments reported to CMS, 2019-2025
27 companies · $5,288 in 2025
The $5,288 reported for 2025 was more than what 93% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.42 · 2020: $5,300 · 2021: $305 · 2022: $3,228 · 2023: $850 · 2024: $612 · 2025: $5,288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,087 · Food and Beverage: $2,253 · Consulting Fee: $910 · Honoraria: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,087.08 |
| Food and Beverage | $2,253.43 |
| Consulting Fee | $910.00 |
| Honoraria | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $5,300.00 | 2020 | |
| Baudax Bio INC. | $3,076.55 | 2021-2022 | |
| Smith+Nephew, INC. | $1,883.03 | 2024-2025 | Pico, Grafix, Versajet |
| Tela Bio, INC. | $1,768.99 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Abbvie INC. | $907.44 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $500.00 | 2023 | |
| Axogen | $377.08 | 2022-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Medtronic, INC. | $357.49 | 2022-2025 | Ligasure, Venaseal, Merocel |
| Kerecis Limited | $330.00 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Ethicon US, LLC | $326.71 | 2025 | Stratafix, Vistaseal, Dermabond Prineo |
| Integra Lifesciences Corporation | $140.83 | 2023-2025 | Integra, Tenoglide, Integra Dermal Regeneration Template |
| Allergan, INC. | $111.39 | 2021 | |
| Becton, Dickinson and Company | $99.77 | 2023 | Phasix Mesh |
| Revance Therapeutics, INC. | $92.50 | 2024-2025 | Daxxify |
| W. L. Gore & Associates, INC. | $66.45 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $48.68 | 2025 | |
| Kci USA, INC. | $41.25 | 2023 | |
| Depuy Synthes Sales INC. | $27.59 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.93 | 2025 | Iovera |
| Lifenet Health | $22.59 | 2024 | Theragenesis Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $21.63 | 2025 | |
| Novo Nordisk INC | $21.25 | 2025 | Wegovy |
| Acera Surgical, INC. | $19.26 | 2024 | Restrata Wound Matrix |
| Tei Biosciences INC | $18.83 | 2019 | |
| Polynovo North America LLC | $17.94 | 2023 | |
| Pylant Medical | $16.05 | 2025 | |
| Checkpoint Surgical, INC | $13.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Solomon Azouz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.